Source:http://linkedlifedata.com/resource/pubmed/id/10639582
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2000-3-7
|
pubmed:abstractText |
Newcastle Disease Virus (NDV), an agent with interesting immune stimulatory and anti-tumor activity, was investigated for its capacity to activate anti-tumor activity in murine macrophages in vitro and in vivo. Direct macrophage activation was seen under a variety of experimental conditions using two different strains of NDV, different sources of macrophages (spleen and peritoneum) and different strains of mice (DBA/2, C57BL/6, 615). Various macrophage enzymes (ADA, iNOS, lysozyme, acid phosphatase) became upregulated and anti-tumor effector molecules such as nitric oxide (NO) and TNF-alpha were found in the supernatant. NDV activated macrophages performed anti-tumor activity in vitro such as anti-tumor cytostasis and anti-tumor cytotoxicity. The cytotoxic anti-tumor activity was broad and active against all tumor lines tested including mammary carcinoma, lung carcinoma, mastocytoma and immune escape variants (lymphoma). Macrophage activation via BCG/LPS also caused a broad range anti-tumor cytotoxic activity while activation via mixed lymphocyte culture conditioned medium had restricted anti-tumor activity. Anti-tumor activity of NDV activated macrophages could be transfered in vivo. Transfer of macrophages which had not been appropriately activated exerted either no effect or a tumor growth augmenting effect. Repeated intravenous transfer of NDV activated macrophages exerted a significant suppressive effect on pulmonary metastases in a mammary carcinoma tumor model as well as in a lung carcinoma model. Taken together these results demonstrate that NDV can strongly activate macrophages to perform anti-tumor activities in vitro and in vivo.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1019-6439
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
363-73
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:10639582-Animals,
pubmed-meshheading:10639582-Female,
pubmed-meshheading:10639582-Lung Neoplasms,
pubmed-meshheading:10639582-Macrophage Activation,
pubmed-meshheading:10639582-Macrophages,
pubmed-meshheading:10639582-Mammary Neoplasms, Animal,
pubmed-meshheading:10639582-Mice,
pubmed-meshheading:10639582-Mice, Inbred C57BL,
pubmed-meshheading:10639582-Mice, Inbred DBA,
pubmed-meshheading:10639582-Newcastle disease virus,
pubmed-meshheading:10639582-Nitric Oxide,
pubmed-meshheading:10639582-Tumor Necrosis Factor-alpha
|
pubmed:year |
2000
|
pubmed:articleTitle |
Newcastle disease virus activates macrophages for anti-tumor activity.
|
pubmed:affiliation |
German Cancer Research Center (DKFZ), Division of Cellular Immunology, D-69120 Heidelberg, Germany.
|
pubmed:publicationType |
Journal Article
|